|
카테고리
|
Cytokines & Growth Factor
|
|
CAT.NO
|
LGP-15-006
|
|
PRODUCT
|
IL-1β, Equine (Interleukin-1 beta)
|
|
SIZE
|
10ug, 100ug, 250ug
|
|
PRICE
|
KRW 285,000, 1,522,000, 2,622,000
|
Technical Parameters
| Synonyms |
IL-1 beta |
| Accession |
Q28386 |
| GeneID |
100034237 |
| Source |
Escherichia coli. |
| Molecular Weight |
Approximately 17.3 kDa, a single non-glycosylated polypeptide chain containing 153 amino acids. |
| Quantity |
10µg/100µg/250µg |
| AA Sequence |
AAMHSVNCRL RDIYHKSLVL SGACELQAVH LNGENTNQQV VFCMSFVQGE EETDKIPVAL GLKEKNLYLS CGMKDGKPTL QLETVDPNTY PKRKMEKRFV FNKMEIKGNV EFESAMYPNW YISTSQAEKS PVFLGNTRGG RDITDFIMEI TSA |
| Purity |
> 95 % by SDS-PAGE and HPLC analyses. |
| Biological Activity |
Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine D10S cells is less than 20 pg/ml, corresponding to a specific activity of > 5.0 × 107 IU/mg. |
| Physical Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
| Formulation |
Lyophilized from a 0.2 μm filtered concentrated solution in 1 × PBS, pH 7.4, 0.1 % Tween-80. |
| Endotoxin |
Less than 1 EU/μg of rEqIL-1β as determined by LAL method. |
| Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| Usage |
This material is offered by Korea Lugen Sci for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. |
| SDS-PAGE |
 |
| Reference |
1. Bankers-Fulbright, J.L., K.R. Kalli, and D.J. McKean. 1996. Life Sci, 59: 61-83.
2. Dinarello, C.A. 1997. Semin Oncol, 24: S9-81-S9-93.
3. Martinon, F., and J. Tschopp. 2007. Cell Death Differ, 14: 10-22.
4. Auron, P.E., A.C. Webb, L.J. Rosenwasser, et al. 1984. Proc Natl Acad Sci U S A, 81: 7907-11. |
| Background |
Interleukin-1 beta (IL-1β) is a non-secreted proinflammatory cytokine produced mainly by activated macrophages, as well as neutrophils, epithelial cells, and endothelial cells. It possesses metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. Both IL-1α and IL-1β binds to the same receptor and has similar but not identical biological properties. Recombinant equine interleukin-1 beta is a 17 kDa protein containing 153 amino acid residues and it shares 63 %~70 % a.a. sequence identity with canine, cotton rat, porcine, feline, human, mouse, rat, and rhesus IL1β. |
|
|
첨부파일
|
|
|
|
|
|
